The Inquiry has published its first report and recommendations following its investigation into the UK’s ‘Resilience and preparedness (Module 1)’.
[Automatic translation disclaimer]
INQ000177801 – Joint witness statement of Chris Llewelyn and Mark Lloyd, dated 20/04/2023
Royal Pharmaceutical Society – Appointment of Recognised Legal Representative – dated 4 July 2023